The mutational landscape of meningioma has expanded following the use of the new
genetic sequencing approaches. Novel mutations have been characterized and reveal their …

Meningiomas are common intracranial tumors with a female predominance. Their etiology is
still poorly documented. The role of sexual hormones has long been evoked, and data have …

Objective To assess the risk of meningioma associated with use of high dose cyproterone
acetate, a progestogen indicated for clinical hyperandrogenism. Design Observational …

Background The optimal management of petroclival meningiomas (PCMs) continues to be
debated along with several controversies that persist. Methods A task force was created by …

Background and purpose A dose‐dependent association between the use of cyproterone
acetate (CPA) and intracranial meningioma has been identified but data for other potent …

The influence of exposure to hormonal treatments, particularly cyproterone acetate (CPA),
has been posited to contribute to the growth of meningiomas. Given the widespread use of …

Background The study the characteristics of surgical meningiomas in female patients who
took CPA and to compare this population to a non-CPA control group. Materials and …

Objective The great heterogeneity of meningiomas is challenging and we need to
distinguish relevant subgroups. Spheno-orbital osteomeningiomas (SOOM) constitute a …

Purpose To report the results of systematic meningioma screening program implemented by
French authorities in patients exposed to progestin therapies (cyproterone (CPA) …

Purpose The improving knowledge of interactions between meningiomas and progestin
refines the management of this specific condition. We assessed the changes over time of the …